Laddar...
Update on imatinib for gastrointestinal stromal tumors: duration of treatment
Gastrointestinal stromal tumors (GISTs) are the most common sarcoma of the gastrointestinal tract, with transformation typically driven by activating mutations of c-KIT and less commonly platelet-derived growth factor receptor alpha (PDGFRA). Successful targeting of c-KIT and PDGFRA with imatinib, a...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3735340/ https://ncbi.nlm.nih.gov/pubmed/23935374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S31260 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|